What is Vera Therapeutics's operating lease liabilities?

Vera Therapeutics (VERA) reported operating lease liabilities of -$182K in Q1 2026.

How has Vera Therapeutics's operating lease liabilities changed year-over-year?

Vera Therapeutics's operating lease liabilities increased by 53.8% year-over-year, from -$394K to -$182K.

Vera Therapeutics VERA Operating lease liabilities

Operating lease liabilities at other companies

Aurinia PharmaceuticalsAUPH

——

ImmunomeIMNM

——

Iovance Biotherapeutics, Inc.IOVA

——

Vir Biotechnology, Inc.VIR

——

TG TherapeuticsTGTX

——

PVL

Palvella TherapeuticsPVLA

——

Other financials

Income statement

See full

Operating income-$125.1M-119%

Net income-$121.0M-134%

EPS (diluted)-$1.69-109%

Balance sheet

See full

Cash & equivalents$114.4M+108%

Total debt$75.0M+37.8%

Total equity$499.7M-6.6%

Total assets$621.7M+1.9%

Cash flow

See full

Operating cash flow-$106.5M-95.8%

CapEx$23.0K-87.7%

Free cash flow-$106.5M-95.1%

Valuation

See full

Market cap$2.74B+87.5%

Enterprise value$2.7B+85.0%

Returns & leverage

See full

Return on equity-71.3%+296pp

Debt / equity0.2×0.0×

Current ratio13.6×-14.0×

Where this comes from

Reported directly by Vera Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The official record: Vera Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vera Therapeutics's operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vera Therapeutics's operating lease liabilities?: Vera Therapeutics (VERA) reported operating lease liabilities of -$182K in Q1 2026.
How has Vera Therapeutics's operating lease liabilities changed year-over-year?: Vera Therapeutics's operating lease liabilities increased by 53.8% year-over-year, from -$394K to -$182K.